3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
16
Carcinoma, Non-Small-Cell Lung
10
Ovarian Neoplasms
6
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Melanoma
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Osteosarcoma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lung Neoplasms
2
Colonic Neoplasms
2
Rhabdomyosarcoma
1
Recurrence
1
Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
1
Neuroblastoma
1
Neoplasms by Site
1
Hodgkin Disease
1
Hepatoblastoma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fibrolamellar hepatocellular carcinoma
1
Fallopian Tube Neoplasms
1
Ependymoma
1
Digestive System Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Renal Cell
1
Interventions
dostarlimab
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
×
dostarlimab
×
Clear all
NCT06879717
2026-01-16
PULMO-01
iOnctura
Phase 1/2
Active not recruiting
45 enrolled